The study is interesting because it evaluates PN (polynucleotide) therapy as a standalone treatment rather than combining it with lasers, microneedling, or subcision. Although this study did not evaluate microneedling, it is relevant because it suggests that PN may independently improve skin texture and atrophic acne scarring. This supports the rationale for investigating whether PN-HPT used alongside microneedling could enhance treatment outcomes.

Most acne scar treatments involve tissue injury and remodeling. Polynucleotides are proposed to improve tissue regeneration and fibroblast activity. If future studies confirm these findings, PN could become a less invasive adjunct or alternative for selected patients. The before and after images included in the paper show visible improvement in some patients, particularly in skin texture and scar appearance. However, photographic interpretation should always be viewed as supportive rather than conclusive evidence. 

There are limitations of this study so I think these findings should be considered preliminary research. It's a small sample size, for an early pilot study this is acceptable, but it limits statistical power and makes it difficult to generalize results broadly. They use a narrow patient population like it only included Caucasian women that were 30-50 years old. So we don't know what the similar results would be in men, young patients, older patients, other skin tones and ethnic groups, or different types of acne scars. And there's a short follow up, they were only evaluated up to three months after treatment, but acne scar remodeling is often a long term process so a follow up that would look at 6 months to a year would strengthen this imo. Because the study was conducted by a small research team, independent replication would be valuable. Findings become much more convincing when multiple groups obtain similar results.

The conclusions are reasonable though. The authors conclude that PN-HPT appeared safe and more effective than placebo in this small randomized study and that larger studies are needed. That conclusion is proportional to the evidence that was presented and they do not overstate the findings by claiming PN-HPT is the best acne scar treatment or that the question is settled. Their conclusion remains appropriately cautious. All in all I'd say this is stronger than a case report or case series, stronger than an uncontrolled observational study, weaker than a large multicenter randomized controlled trial, and useful as pilot evidence that supports further investigation.

Araco A, Araco F. Preliminary Prospective and Randomized Study of Highly Purified Polynucleotide vs Placebo in Treatment of Moderate to Severe Acne Scars. Aesthet Surg J. 2021 Jun 14;41(7):NP866-NP874. doi: 10.1093/asj/sjab125. PMID: 33755110.

Preliminary Prospective and Randomized Study of Highly Purified Polynucleotide (PN) vs Placebo in Treatment of Moderate to Severe Acne Scars